Zobrazeno 1 - 6 of 6 pro vyhledávání: '"Steffi Turzer"'
1
Akademický článek
Monitoring Blood Immune Cells in Patients with Advanced Small Cell Lung Cancer Undergoing a Combined Immune Checkpoint Inhibitor/Chemotherapy
Autor: Dagmar Riemann, Steffi Turzer, Georgi Ganchev, Wolfgang Schütte, Barbara Seliger, Miriam Möller
Publikováno v: Biomolecules, Vol 13, Iss 2, p 190 (2023)
In this exploratory prospective observational study on 40 small cell lung cancer (SCLC) patients treated with a combination of chemotherapy and immune checkpoint inhibitors, blood immune cells were characterized by multi-color flow cytometry at the b
Externí odkaz: https://doaj.org/article/06273a450dcb43fdb77f6061122d3f65
Zobrazit plný text záznamu
2
Blood Immune Cell Biomarkers in Lung Cancer Patients Undergoing Treatment with a Combination of Chemotherapy and Immune Checkpoint Blockade
Autor: Miriam Möller, Steffi Turzer, Georgi Ganchev, Andreas Wienke, Wolfgang Schütte, Barbara Seliger, Dagmar Riemann
Publikováno v: Cancers; Volume 14; Issue 15; Pages: 3690
Although immune checkpoint inhibitor (ICI) therapies have improved the treatment of patients with advanced non-small cell lung cancer (NSCLC), several patients do not achieve durable clinical responses. Biomarkers for the prediction of therapy respon
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfff7d1a4cf2e639423e26d9d36bdb78
https://pubmed.ncbi.nlm.nih.gov/35954354
Zobrazit plný text záznamu
3
Blood Immune Cell Biomarkers in Patient With Lung Cancer Undergoing Treatment With Checkpoint Blockade
Autor: Steffi Turzer, Miriam Möller, Wolfgang Schütte, Dagmar Riemann, Barbara Seliger
Publikováno v: Journal of Immunotherapy (Hagerstown, Md. : 1997)
Supplemental Digital Content is available in the text.
Characterization of host immune cell parameters before and during immunotherapy is expected to identify predictive biomarkers for clinical outcome. We prospectively monitored blood immune ce
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d14c01902a9b9e9eddbe840090aaf42
http://europepmc.org/articles/PMC7012348
Zobrazit plný text záznamu
5
High PD-L1/CD274 Expression of Monocytes and Blood Dendritic Cells Is a Risk Factor in Lung Cancer Patients Undergoing Treatment with PD1 Inhibitor Therapy
Autor: Dagmar Riemann, Barbara Seliger, Miriam Möller, Steffi Turzer, Wolfgang Schütte
Publikováno v: Cancers, Vol 12, Iss 2966, p 2966 (2020)
Cancers
Volume 12
Issue 10
The aim of this study was to investigate the expression of the coinhibitory molecule PD-L1/CD274 in monocytes and dendritic cells (DC) in the blood of lung cancer patients undergoing PD1 inhibitor therapy and to correlate data with patient&rsquo
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24befcd28bde0c9db55b0aa93f5437cb
https://doi.org/10.3390/cancers12102966
Zobrazit plný text záznamu
6
Blood immune cell biomarkers in lung cancer
Autor: T Giese, M Grallert, M Cwikowski, Dagmar Riemann, Barbara Seliger, Steffi Turzer, Wolfgang Schütte
Publikováno v: Clinical and experimental immunology. 195(2)
Summary Characterization of host immune cell parameters prior to treatment is expected to identify biomarkers predictive of clinical outcome as well as to elucidate why some patients fail to respond to immunotherapy. We monitored blood immune cells f
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09b40df686e47d4010638fce1da58928
https://pubmed.ncbi.nlm.nih.gov/30246868
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje